DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding DMK Pharmaceuticals Corp changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 25 | 29 | +4 |
| Shares | 259.2K | 500.5K | +241.3K (+93.1%) |
| Value | $178.7K | $350.4K | +$171.7K (+96.1%) |
New holders (7)
Institutions that held DMK Pharmaceuticals Corp at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 103,493 | $72.5K | 0.00% |
| Susquehanna International Group, LLP | 20,237 | $14.2K | 0.00% |
| HRT Financial LP | 16,558 | $11.0K | 0.00% |
| Life Planning Partners, Inc | 304 | $213 | 0.00% |
| Advisory Services Network, LLC | 71 | $50 | 0.00% |
| Clear Point Advisors Inc. | 53 | $37 | 0.00% |
| FMR LLC | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held DMK Pharmaceuticals Corp at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| StoneX Group Inc. | 13,258 | $9.13K |
| XTX Topco Ltd | 12,024 | $8.29K |
| Qube Research & Technologies Ltd | 100 | $69 |